US Drug Recall Register
Class II · Moderate risk Ongoing Initiated Jul 30, 2025 (13 months ago)

Tirzepatide, 60mg/10 mL for Injection, 10mL vial lyophilized, all presentations…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Assurance of Sterility

What was recalled

Tirzepatide, 60mg/10 mL for Injection, 10mL vial lyophilized, all presentations, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692. Also labeled as manufactured for Extension Health and Synergy Wellness 60mg, 10mL vial lyophilized.

Recalling firm
GenoGenix LLC
Origin
FL, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0092-2026

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Tirzepatide recalls

See all